Signal transducer and activator of transcription 3 (STAT3) has been shown previously to be a key signaling protein driving major hallmarks of cancer, including proliferation and cell survival, and to represent a promising target for the development of targeted glioblastoma therapies. Here, STAT3 is linked to glioblastoma.